Free Trial

OptimizeRx (OPRX) SEC Filings & 10K Form

OptimizeRx logo
$5.15
-0.07 (-1.34%)
(As of 11/1/2024 ET)

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
10/15/2024
3:53 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:30 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:26 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:25 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
4:22 PM
McCarthy Brian Clark (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:45 PM
OptimizeRx (Filer)
Form S-8 POS
06/12/2024
10:41 AM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:47 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
HALAS GUS D (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:49 PM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:50 PM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:46 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:00 AM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
05/15/2024
4:01 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:10 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
8:32 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:34 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:35 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:35 AM
OptimizeRx (Filer)
Form DEF 14A
04/29/2024
7:38 AM
OptimizeRx (Filer)
Form ARS
04/22/2024
7:37 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/22/2024
7:31 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/18/2024
3:30 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:22 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:41 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:15 AM
OptimizeRx (Filer)
Form NT 10-K
03/06/2024
3:19 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:22 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:23 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:24 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:16 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:53 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2024
3:00 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
4:56 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

01/11/2024
4:06 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:19 PM
OptimizeRx (Filer)
Form 8-K/A
12/29/2023
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/13/2023
1:32 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
6:15 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
9:49 AM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners